scispace - formally typeset
H

Huahao Shen

Researcher at Zhejiang University

Publications -  221
Citations -  7335

Huahao Shen is an academic researcher from Zhejiang University. The author has contributed to research in topics: Inflammation & Asthma. The author has an hindex of 38, co-authored 199 publications receiving 5283 citations. Previous affiliations of Huahao Shen include Guangzhou Medical University.

Papers
More filters
Journal ArticleDOI

YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling

TL;DR: YKL-40 expression is up-regulated in patients with COPD and correlates with exacerbation attacks and may contribute to airway remodeling by acting on lung fibroblasts.
Journal ArticleDOI

Activating transcription factor 3 represses cigarette smoke-induced IL6 and IL8 expression via suppressing NF-κB activation.

TL;DR: This study shows that ATF3 plays an important role in the negative regulation of CS-induced pro-inflammatory gene expression through downregulating NF-κB phosphorylation.
Journal ArticleDOI

The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma.

TL;DR: The CKLF1‐C19 peptide attenuates allergic lung inflammation by inhibiting CCR3‐ and CCR4‐mediated chemotaxis in a mouse model of asthma.
Journal ArticleDOI

Transgelin overexpression in lung adenocarcinoma is associated with tumor progression

TL;DR: TAGLN was upregulated in the human lung adenocarcinoma cell lines under hypoxic conditions, which contributed to the migration ability of the cells, and the data suggest that TAGLN may be a viable therapeutic target and a potential biomarker for predicting the prognosis of patients with lung adentheses.
Journal ArticleDOI

Autophagy inhibitors suppress environmental particulate matter-induced airway inflammation.

TL;DR: This study shows a paradigm that autophagy inhibitors effectively decrease the PM-induced airway inflammation via suppressing the NF-кB pathway, which may provide novel preventive and/or protective approaches for PM-related airway injury.